Valuation : Avantor, Inc.

Market Cap 983.43Cr 846.73Cr 795.05Cr 725.75Cr 1.36TCr 94TCr 1.37TCr 9.42TCr 3.67TCr 47TCr 3.69TCr 3.61TCr 1,57100Cr P/E 2026 *
43.5x
P/E 2027 * 31.2x
Enterprise Value 1.29TCr 1.11TCr 1.04TCr 952.49Cr 1.79TCr 1,22800Cr 1.8TCr 12TCr 4.81TCr 62TCr 4.85TCr 4.74TCr 2,06200Cr EV / Sales 2026 *
1.96x
EV / Sales 2027 * 1.82x
Free-Float
95.5%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 18/08/2025
Director of Finance/CFO 50 24/06/2026
Chief Operating Officer - 10/11/2025
Director TitleAgeSince
Director/Board Member 60 22/04/2020
Chairman 69 01/01/2026
Director/Board Member 62 01/10/2021
Date Insider Type Main position Quantity % Market Cap. Importance
18/08/26 Tax

Chief Executive Officer

-29,803 0.0044%
14/08/26 Tax

Head of Human Resources

-181 0.0000%
31/07/26 Tax

Chief Financial Officer

-1,385 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.27%+1.96% - - 983.43Cr
-1.88%-5.41%-16.81%+7.25% 19TCr
-0.64%-2.42%-2.33%+11.23% 12TCr
+0.49%-0.05%+10.97%+83.88% 6.18TCr
-0.74%-1.38%-2.52%-32.69% 5.12TCr
+1.18%-0.02%+29.20%+54.07% 5.15TCr
+0.26%-.--%+22.56%-9.82% 3.44TCr
-0.71%+0.95% - - 3.07TCr
+1.08%-3.46%+38.13%-16.17% 2.4TCr
+1.13%-1.96%-5.16%+15.32% 2.32TCr
Average -0.01%-1.08%+9.25%+14.13% 5.94TCr
Weighted average by Cap. -0.58%-1.86%+0.26%+15.56%

Financials

2026 *2027 *
Net sales 659.37Cr 567.72Cr 533.07Cr 486.6Cr 914.13Cr 63TCr 920.68Cr 6.32TCr 2.46TCr 32TCr 2.48TCr 2.42TCr 1,05300Cr 674.97Cr 581.15Cr 545.68Cr 498.12Cr 935.76Cr 64TCr 942.46Cr 6.47TCr 2.52TCr 33TCr 2.53TCr 2.48TCr 1,07800Cr
Net income 23Cr 19Cr 18Cr 17Cr 31Cr 2.14TCr 31Cr 215.68Cr 84Cr 1.09TCr 85Cr 83Cr 3.6TCr 31Cr 27Cr 25Cr 23Cr 43Cr 2.96TCr 43Cr 297.72Cr 115.84Cr 1.5TCr 116.69Cr 114.15Cr 4.96TCr
Net Debt 307.24Cr 264.53Cr 248.39Cr 226.74Cr 425.95Cr 29TCr 429Cr 2.94TCr 1.15TCr 15TCr 1.15TCr 1.13TCr 49TCr 244.13Cr 210.19Cr 197.37Cr 180.16Cr 338.45Cr 23TCr 340.88Cr 2.34TCr 909.94Cr 12TCr 916.63Cr 896.71Cr 39TCr
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company's segments include Bioscience & Medtech Products and VWR Distribution & Services. Through these segments, it provides materials and consumables, equipment and instrumentation and services and specialty procurement to customers in biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and others.
Employees
13,500
Date Price Change
31/26/31 $14.54 -0.27%
28/26/28 $14.58 -0.21%
27/26/27 $14.61 +0.76%
26/26/26 $14.50 +0.55%
25/26/25 $14.42 +1.12%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
14.54USD
Average target price
14.56USD
Spread / Average Target
+0.17%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AVTR Stock